← Back to Screener
Scilex Holding Company Warrant (SCLXW)
Price$0.14
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-6.69%
Price vs S&P 500 (4W)-32.28%
VGM Score62.24
All Metrics
Price vs S&P 500 (YTD)38.10%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.01M
52-Week High$0.65
26-Week Price Return5.04%
13-Week Price Return-6.75%
3-Month Return Std Dev231.89%
Year-to-Date Return47.10%
5-Day Price Return16.33%
Month-to-Date Return-0.36%
Price vs S&P 500 (13W)-17.61%
Beta4.97x
52-Week Low$0.05
mGradeB
vgmGradeB
Show chart for
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SCLXWScilex Holding Company Warrant | — | — | B | $0.14 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Scilex Holding Co develops and commercializes non-opioid pain management products, including approved therapies ZTlido (topical lidocaine for post-shingles nerve pain) and Gloperba (oral colchicine for gout flare prevention). The company also maintains a pipeline of three clinical-stage candidates.